Long COVID update: respiratory sequelae and symptoms
- PMID: 40170623
- DOI: 10.1097/SPC.0000000000000755
Long COVID update: respiratory sequelae and symptoms
Abstract
Purpose of review: Long COVID affects approximately 6% of the population after SARS-CoV-2 infection commonly involving persistent respiratory symptoms such as breathlessness and cough. This review provides an update on the latest evidence regarding post-COVID condition/Long COVID and respiratory sequelae, focusing on persistent symptoms, respiratory complications, and therapeutic approaches to date.
Recent findings: Post-COVID interstitial lung abnormalities are estimated to persist in approximately 11% of patients hospitalized with acute COVID-19. However, breathlessness is common in adults (non-hospitalized) with Long COVID, suggesting aetiologies beyond pneumonitis. The risk of venous thromboembolic disease in Long COVID remains uncertain and trial results of anti-coagulation in Long COVID are awaited.
Summary: Long COVID presents complex respiratory challenges, and careful assessment is crucial to differentiate Long COVID symptoms from exacerbations of pre-existing respiratory conditions. Current management includes a symptom-based multidisciplinary approach, with ongoing research into effective treatments including immune modulating agents.
Keywords: Long COVID; breathing-pattern disorder; breathlessness; post-COVID interstitial lung abnormality; rehabilitation; respiratory sequelae.
Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
Similar articles
-
Respiratory sequelae of COVID-19: pulmonary and extrapulmonary origins, and approaches to clinical care and rehabilitation.Lancet Respir Med. 2023 Aug;11(8):709-725. doi: 10.1016/S2213-2600(23)00159-5. Epub 2023 May 19. Lancet Respir Med. 2023. PMID: 37216955 Free PMC article. Review.
-
Post-COVID Interstitial Lung Disease: How do We Deal with This New Entity?Balkan Med J. 2024 Sep 6;41(5):377-386. doi: 10.4274/balkanmedj.galenos.2024.2024-3-82. Epub 2024 Aug 28. Balkan Med J. 2024. PMID: 39192585 Free PMC article.
-
Persistent Post-COVID-19 Interstitial Lung Disease. An Observational Study of Corticosteroid Treatment.Ann Am Thorac Soc. 2021 May;18(5):799-806. doi: 10.1513/AnnalsATS.202008-1002OC. Ann Am Thorac Soc. 2021. PMID: 33433263 Free PMC article.
-
[Pulmonary manifestations in long COVID].Inn Med (Heidelb). 2022 Aug;63(8):819-829. doi: 10.1007/s00108-022-01371-3. Epub 2022 Jul 7. Inn Med (Heidelb). 2022. PMID: 35925073 Free PMC article. Review. German.
-
Immunofibrotic drivers of impaired lung function in postacute sequelae of SARS-CoV-2 infection.JCI Insight. 2021 Jul 22;6(14):e148476. doi: 10.1172/jci.insight.148476. JCI Insight. 2021. PMID: 34111030 Free PMC article.
References
-
- Office of National Statistics (ONS). Self-reported Coronavirus (COVID-19) Infections and Associated Symptoms, England and Scotland: November 2023 to March 2024. Office of National Statistics; 2024. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/... . [Accessed 12 February 2025].
-
- Thomas C, Faghy MA, Owen R, et al. Lived experience of patients with Long Covid: a qualitative study in the UK. BMJ Open 2023; 13:e068481.
-
- Brannock MD, Chew RF, Preiss AJ, et al. Long COVID risk and pre-COVID vaccination in an EHR-based cohort study from the RECOVER program. Nat Commun 2023; 14:2914.
-
- Roche N, Crichton ML, Goeminne PC, et al. Update June 2022: management of hospitalised adults with coronavirus disease 2019 (COVID-19): a European Respiratory Society living guideline. Eur Respir J 2022; 60:2200803.
-
- Hastie CE, Lowe DJ, McAuley A, et al. True prevalence of long-COVID in a nationwide, population cohort study. Nat Commun 2023; 14:7892.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous